Ua ʻike ʻia ka mālama ʻana o ka laser CO2 microblative fractional he pono a palekana hoʻi i ka mālama ʻana i ka vulvovaginal atrophy i ka manawa pōkole, e like me kahi noiʻi i paʻi ʻia ma ka puke pai Menopause.
Ua loaʻa i ka loiloi pakuhi retrospective he 139 mau wahine me nā hōʻailona atrophy vulvovaginal, nāna i hoʻopau i ʻekolu mau kau laser ma kahi o 6 mau pule ma ke keʻena ʻo Vulvar and Sexual Health ma Prohealth, Waukesha Memorial Hospital, ma Wisconsin, mai Ianuali 2016 a hiki i Dekemaba 2019.
ʻO nā maʻi a pau ma luna o 18 mau makahiki (ʻo ka awelika makahiki he 62) a ʻaʻole i hāpai.
Ua hōʻike ʻia ka estrogen topical like ʻana ma 53% o nā maʻi (n = 74). ua hoʻopaʻa ʻia ka ʻike ʻana i ka maʻi ʻaʻai umauma ma 27% (n = 38) a me ka lichen sclerosus ma 22% (n = 31).
Ua ninaninau ʻia nā maʻi ma mua o ka mālama ʻana i ka laser mua a me ke kolu ma o ʻelua mau nīnau i hōʻoia ʻia: ʻo ka Female Sexual Function Index (FSFI) a me ka Vulvovaginal Symptoms Questionnaire (VSQ). Ua hoʻopiha pū ʻia kahi unahi analog ʻike maka (VAS).
Ua hāʻawi mua ʻia ka lāʻau lapaʻau ma ke ʻano vaginal me ka hoʻohana ʻana i kahi probe vaginal a ukali ʻia e ka lāʻau vulvar i hana ʻia me kahi ʻāpana lima ʻokoʻa, me ka hoʻohana ʻana i kahi ʻano huinaha. Ua hoʻopili ʻia ʻo Lidocaine 2% i ka ʻiʻo vulvar 20 mau minuke ma mua o ka lāʻau lapaʻau. Ua hoʻohālikelike ʻia nā hoʻonohonoho laser no nā lāʻau lapaʻau vaginal a me vulvar i nā haʻawina ma mua.
ʻO ka awelika o ka nānā ʻana he 13.8 mau pule.
Ua hoʻomaikaʻi ʻia nā helu FSFI āpau: ma mua o ka mālama ʻana he 12.7 vs. ma hope o ka mālama ʻana he 19.0 (P
Ua hōʻike pū ka VSQ ua hoʻomaikaʻi nui ʻia he 18 o 21 mau nīnau (P
Eia kekahi, ua hōʻike ka VAS i ka hoʻomaikaʻi nui ʻana i ka moekolohe ʻeha a me ka maloʻo o ka vulvar a me ka vaginal: ma mua o ka mālama ʻana he 12.7 a me 4.6, kēlā me kēia vs. ma hope o ka mālama ʻana he 2.4 a me 1.5 (ʻelua P
Eia kekahi, ua lilo nā wāhine ʻē aʻe he 17 i hana moekolohe ma hope o ka lua o ka lāʻau laser. ʻAʻohe hanana koʻikoʻi i hōʻike ʻia ma waena o kekahi o nā mea komo i ke aʻo ʻana.
"Ua kāhāhā mākou i ka holomua ʻana o nā maʻi ma hope o hoʻokahi a ʻelua paha mau lāʻau lapaʻau," wahi a ka mea noiʻi nui ʻo Sarit Aschkenazi MD, MS, ka luna hoʻokele lapaʻau ma ka Halemai Hoʻomanaʻo ʻo Prohealth Waukesha. "Ua hana ʻia ka holomua ʻana i nā wahine me nā hōʻailona koʻikoʻi i pane ʻole i ka lāʻau lapaʻau maʻamau, e like me ka estrogen topical, a i ʻole ka poʻe e lawe ana i nā mea hoʻopaʻa aromatase no ka pale ʻana i ka maʻi ʻaʻai umauma. Ua hauʻoli nui mākou i ka ʻike ʻana i nā wahine me ka lichen sclerosis me ka atrophy ʻili holomua loa e hōʻike ana i nā hōʻailona o ka holomua."
Ua manaʻo ʻia ka hana a ka laser therapy ma ka hāʻawi ʻana i ka ikehu i ka ʻiʻo subcutaneous, me ka hōʻino liʻiliʻi i ka epithelium ma luna. Hoʻoulu ia i nā fibroblasts e hana i nā olonā collagen a me elastin hou aʻe, a hoʻonui pū i ka nui o ka wai, nā ʻili ʻili, a me ka mānoanoa epithelial o ka ʻili vaginal a me vulvar, e like me Aschkenazi.
"Ua like kēia me nā hopena i hana ʻia ke kau ʻia ka laser i ka ʻili o ka maka," wahi āna. "Ua hoʻohana ʻia ka laser ma ka ʻili o ka maka no nā makahiki he ʻumi a ua palapala ʻia he palekana. Ua hōʻike pū ʻia nā biopsies ʻili i kēia mau hopena. Ua like kēia mau hoʻololi a pau me nā loli e kū mai ana i ka wā e loaʻa ai ka estrogen i loko o ka ʻiʻo i nā pae premenopausal."
Ke hōʻike nei ka laser he lāʻau lapaʻau ʻē aʻe e hoʻohiki nei no kahi maʻi maʻamau e like me ka vulvovaginal atrophy. "He koho hou kēia ke ʻaʻole pono ka estrogen, contraindicated a i ʻole makemake ʻole ʻia," wahi a Aschkenazi.
Eia nō naʻe, pono nā haʻawina hoʻomalu randomized e hoʻoholo maopopo i ka pono o ka mālama ʻana i ka laser, a me ka hoʻokumu ʻana i ka helu kūpono o nā kau lapaʻau, nā wā a me ka pinepine e hana hou ai i kahi booster.
"ʻO kahi koho lapaʻau e loiloi ai, ʻo ia ka hoʻohui ʻana i ka laser therapy me ka lāʻau hormonal topical, ke ʻole e kūʻē ʻia, e like me ka estrogen therapy a i ʻole ka topical dehydroepiandrosterone (DHEA) e hoʻolōʻihi i ka hoʻomaikaʻi ʻana o nā ʻiʻo a loaʻa kahi hopena synergistic ma nā haʻahaʻa haʻahaʻa," wahi a Aschkenazi.
ʻOiai ua ʻike ʻia ka palekana o ka laser i nā maʻi āpau i noiʻi ʻia, paipai ʻo Aschkenazi i ka hoʻohana ʻana i nā koho lapaʻau maʻamau no nā hōʻailona atrophy vulvovaginal ma mua o ka hoʻohui ʻana i ka lāʻau laser, a me ka hahai ʻana i nā palena lapaʻau e pale aku i nā hopena maikaʻi ʻole. Pono ka poʻe e hakakā nei me ia mau hōʻailona e mālama i ka mālama ʻili ma ka hōʻemi ʻana i nā mea hoʻonāukiuki ʻili, nā lole komo paʻa, ke kopa a me nā pads wahine ʻala. "ʻO ka hoʻohui ʻana i nā moisturizers nonhormonal e kōkua i ka pale ʻana i ka maloʻo e pili ana me nā hōʻailona menopausal," wahi āna.
ʻO ka lāʻau lapaʻau laser CO2 fractional no ka atrophy vulvovaginal Video pili:
"ʻO ke kūlana mua, ʻo ka ʻoiaʻiʻo ma ke kumu, ke kākoʻo ʻoiaʻiʻo a me ka loaʻa kālā like" ko mākou manaʻo, i mea e kūkulu hou ai a alualu i ka maikaʻi no Kūʻai nui no ka wehe ʻana i ka lauoho , Mīkini Ipl Lapaʻau , Laser Mana Kiʻekiʻe , Ua hoʻokuʻu nui ʻia aku kā mākou huahana i ka hema hikina o ʻAsia Euro-ʻAmelika, a kūʻai aku i ko mākou ʻāina holoʻokoʻa. A ma muli o ke ʻano maikaʻi loa, ke kumukūʻai kūpono, ka lawelawe maikaʻi loa, loaʻa iā mākou nā manaʻo maikaʻi mai nā mea kūʻai aku ma nā ʻāina ʻē. Ua hoʻokipa ʻia ʻoe e hui pū me mākou no nā mea hiki a me nā pono hou aʻe. Hoʻokipa mākou i nā mea kūʻai aku, nā hui ʻoihana a me nā hoaaloha mai nā wahi a pau o ka honua e hoʻokaʻaʻike mai iā mākou a ʻimi i ka laulima no nā pono like.